Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes
Recruiting
Phase 3
Interventional Study
Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 40 and older
- Sex
- Male
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Benha University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intra-Prostatic Epinephrine injection in Bipolar Transurethral resection of large prostate: Exploring Its Role in Optimizing Surgical Outcomes
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Indication for Prostate Surgery or Procedure - Patients undergoing transurethral resection of the prostate (TURP)
* Prostate from 80 to 100 gm
* Failed medical therapy
Exclusion Criteria:
* Uncontrolled Hypertension - Patients with significantly high blood pressure despite m…
Contacts
No contact information available.